Screening for deficits using the G8 and VES-13 in older patients with Myelodysplastic syndromes

Angela Molga, Michelle Wall, Li Yan A. Wee, Rakchha Chhetri, Deepak Singhal, Nimit Singhal, Luen Bik To, Sepehr Shakib, Timothy To, Devendra Hiwase

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)

Abstract

The incidence of myelodysplastic syndromes (MDS) increases with age. Older patients with MDS have a poor prognosis, further influenced by individual factors such as comorbidity, functional status and cognitive status [1]. Currently, patient's performance status is assessed using criteria outlined by Eastern Cooperative Oncology Group (ECOG). An ECOG score of 0–2 is considered ‘fit’, while a score of 3 is considered ‘vulnerable’. Routine hematology assessment does not routinely identify all geriatric related health issues and hence a comprehensive geriatric assessment (CGA) is recommended to detect vulnerability to adverse outcomes in older patients with cancer [2].
Original languageEnglish
Pages (from-to)128-130
Number of pages3
JournalJournal of Geriatric Oncology
Volume11
Issue number1
DOIs
Publication statusPublished - Jan 2020
Externally publishedYes

Keywords

  • Myelodysplastic syndromes
  • Screening
  • G8
  • VES-13

Fingerprint Dive into the research topics of 'Screening for deficits using the G8 and VES-13 in older patients with Myelodysplastic syndromes'. Together they form a unique fingerprint.

Cite this